Results 41 to 50 of about 4,708 (180)
Community-based ototoxicity monitoring with extended high-frequency audiometry and community health workers for drug-resistant tuberculosis [PDF]
Thesis (PhD (Audiology))--University of Pretoria, 2022.Community-based ototoxicity monitoring with extended high-frequency audiometry and community health workers for drug-resistant tuberculosis Name: Lucia Jane Stevenson Supervisor: Professor De ...
Leigh Biagio de Jager (8343393) +2 more
core +2 more sources
Introduction: Aminoglycosides used for treating multidrug-resistant (MDR) tuberculosis are ototoxic, leading to a need for audiological monitoring. While audiologists monitor ototoxicity, currently there are no guidelines on monitoring in the South ...
M. Govender, J. Paken
doaj +1 more source
Otoacoustic emissions: An approach for monitoring aminoglycoside‐induced ototoxicity [PDF]
AbstractOtotoxic drugs, such as aminoglycosides, affect outer hair cell integrity in the inner ear. Transiently evoked otoacoustic emission (TEOAE) characteristics are related to outer hair cell function and can be expected to reflect the influence of ototoxic agents.
Hotz MA, Harris FP, Probst R
openaire +3 more sources
Extended high-frequency audiometry for ototoxicity monitoring (Stevenson et al., 2023)
Purpose: The aim of this study was to describe extended high-frequency (EHF) pure-tone audiometry monitoring of ototoxicity in a longitudinal treatment program for drug-resistant tuberculosis (DRTB).
Marien Alet Graham (14082034) +3 more
core +1 more source
Medical management of Pseudomonas aeruginosa endocarditis: A case report
Background: Pseudomonas aeruginosa is a rare cause of infective endocarditis. There is no standard treatment regimen for the management of infective endocarditis caused by this organism. Pseudomonas aeruginosa produces biofilm on the endocardial surface
Sameer Abdul Samad +5 more
doaj +1 more source
Background Cisplatin is a popular antineoplastic agent used to treat cervical cancer in women from low and middle-income countries. Cisplatin treatment is associated with ototoxicity, often resulting in hearing loss.
Jessica Paken +4 more
doaj +1 more source
Audiological Monitoring of Patients Receiving Ototoxic Drugs [PDF]
Over 200 medications commonly prescribed for the treatment of cancers and some infections can cause inner ear damage, or ototoxicity (ASHA, 2004). Ototoxicity can result in auditory and/or vestibular dysfunction, and the effects can be temporary, but are often permanent.
Dawn Konrad-Martin +5 more
openaire +1 more source
Automated technology for ototoxicity monitoring (Konrad-Martin et al., 2021)
Purpose: Determine the efficacy of ototoxicity monitoring (OM) administered as automated protocols with the Oto-ID mobile audiometer (automated ototoxicity monitoring [A-OM]), compared with usual care (UC) OM in cancer patients receiving cisplatin.Method:
Keri O’Connell Bennett (11458508) +3 more
core +1 more source
Monitoring cisplatin-induced ototoxicity. [PDF]
Introduction and objective: The ototoxic damage goes unnoticed to disabling levels, being justified to apply control for its early detection procedures, make it possible to a therapeutic change and if necessary, a speech and auditory rehabilitation.
José Ignacio BENITO-OREJAS +11 more
core +1 more source
Background: Fourteen million new cancer cases are reported annually, and up to 10% of those involve children below 15 years. Cisplatin, a commonly used anti-cancer drug for its high success rate, is associated with ototoxicity.
Mukovhe Phanguphangu, Lebogang Ramma
doaj +1 more source

